Burning Rock Biotech Limited
BNR
$16.76
-$0.07-0.42%
NASDAQ
| 12/31/2025 | 09/30/2025 | 03/31/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 80.79% | 53.11% | 89.04% | 89.04% | 49.70% |
| Total Depreciation and Amortization | -57.30% | -- | -- | -- | -60.76% |
| Total Amortization of Deferred Charges | -82.92% | -- | -- | -- | -58.12% |
| Total Other Non-Cash Items | -8.87% | 506.49% | -112.17% | -112.17% | 30.87% |
| Change in Net Operating Assets | -64.96% | -- | -- | -- | 29.70% |
| Cash from Operations | 22.65% | 154.16% | 42.25% | 42.25% | 219.44% |
| Capital Expenditure | 1.71% | -- | -- | -- | 32.88% |
| Sale of Property, Plant, and Equipment | -44.39% | -- | -- | -- | 1,775.86% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 35.80% | -178.32% | 36.65% | 36.65% | -60.30% |
| Cash from Investing | 60.05% | -178.32% | 36.65% | 36.65% | -148.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 98.97% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -99,900.00% | -- | -- | -- | -100.04% |
| Cash from Financing | -36.89% | -- | -- | -- | 96.10% |
| Foreign Exchange rate Adjustments | -250.48% | 52.16% | 460.81% | 460.81% | 275.77% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -40.13% | 134.36% | 42.56% | 42.56% | 211.48% |